PeptideDB

EPZ004777 hydrochloride 1380316-03-9

EPZ004777 hydrochloride 1380316-03-9

CAS No.: 1380316-03-9

EPZ004777 hydrochloride, the hydrochloride salt of EPZ-004777, is a novel and potent DOT1L inhibitor with an IC50 value
Sales Email:peptidedb@qq.com

This product is for research use only, not for human use. We do not sell to patients.

EPZ004777 hydrochloride, the hydrochloride salt of EPZ-004777, is a novel and potent DOT1L inhibitor with an IC50 value of 400 pM. DOT1L is a protein methyltransferase catalyzing the methylation of lysine 4 of histone H3 (H3K4).



Physicochemical Properties


Molecular Formula C₂₈H₄₂CLN₇O₄
Molecular Weight 576.13
Exact Mass 575.299
CAS # 1380316-03-9
Related CAS # EPZ004777;1338466-77-5
PubChem CID 67811385
Appearance Light yellow to yellow solid powder
LogP 4.513
Hydrogen Bond Donor Count 6
Hydrogen Bond Acceptor Count 8
Rotatable Bond Count 10
Heavy Atom Count 40
Complexity 788
Defined Atom Stereocenter Count 4
SMILES

CC(C)N(CCCNC(=O)NC1=CC=C(C=C1)C(C)(C)C)C[C@@H]2[C@H]([C@H]([C@@H](O2)N3C=CC4=C(N=CN=C43)N)O)O.Cl

InChi Key NPEPLDAFAVXSBD-XRJUUMFPSA-N
InChi Code

InChI=1S/C28H41N7O4.ClH/c1-17(2)34(13-6-12-30-27(38)33-19-9-7-18(8-10-19)28(3,4)5)15-21-22(36)23(37)26(39-21)35-14-11-20-24(29)31-16-32-25(20)35;/h7-11,14,16-17,21-23,26,36-37H,6,12-13,15H2,1-5H3,(H2,29,31,32)(H2,30,33,38);1H/t21-,22-,23-,26-;/m1./s1
Chemical Name

1-[3-[[(2R,3S,4R,5R)-5-(4-aminopyrrolo[2,3-d]pyrimidin-7-yl)-3,4-dihydroxyoxolan-2-yl]methyl-propan-2-ylamino]propyl]-3-(4-tert-butylphenyl)urea;hydrochloride
Synonyms

EPZ 004777 HCl EPZ-004777 EPZ004777
HS Tariff Code 2934.99.9001
Storage

Powder-20°C 3 years

4°C 2 years

In solvent -80°C 6 months

-20°C 1 month

Note: Please store this product in a sealed and protected environment (e.g. under nitrogen), avoid exposure to moisture and light.
Shipping Condition Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)

Biological Activity


ln Vitro EPZ004777 hydrochloride, with an IC50 of 400±100 pM, has a strong concentration-suspension inhibitory action on DOT1L enzyme activity. On DOT1L, solutions of hydrochloride EPZ004777 suspend more HMTs (PRMT5, 521±137 nM; other, >50 μM). Prolonged HCl treatment with EPZ004777 has a substantial potential impact on MLL-rearranged cell lines. EPZ004777 hydrochloride markedly decreased the amount of viable MV4-11 and MOLM-13 cells, however it took some time for Jurkat cells to start growing. While Part One MV4-11 cells continued to divide when exposed to EPZ004777 hydrochloride, their population size did not alter over time, according to long-term growth curve tracking. At doses of 3 μM or above, EPZ004777 hydrochloride significantly inhibits MLL-AF9. Results MLL-AF10 and CALM-AF10 transformed cells' bone marrow stroma are inhibited by the EPZ004777 hydrochloride cycle [2].
ln Vivo The hydrochloride of EPZ004777 was well tolerated, and no appreciable toxicity was seen. Following 14 days of nonstop exposure to EPZ004777 hydrochloride, a complete blood count study revealed a substantial rise in total leukocytes as a result of an increase in neutrophils, monocytes, and lymphocytes. The hydrochloride dosage of EPZ004777 (50, 100, or 150 mg/mL) was well tolerated, and no appreciable weight loss was seen [1].
Animal Protocol
Dissolved in 15% ethanol, 50% PEG300, 35% water; Mini-pumps containing 100 and 150 mg/mL EPZ004777 solutions; Osmotic pump
A mouse xenograft MV4-11 model of MLL.
References

[1]. Selective killing of mixed lineage leukemia cells by a potent small-molecule DOT1L inhibitor. Cancer Cell. 2011 Jul 12;20(1):53-65.

[2]. Abrogation of MLL-AF10 and CALM-AF10-mediated transformation through genetic inactivation or pharmacological inhibition of the H3K79 methyltransferase Dot1l. Leukemia. 2013 Apr;27(4):813-22.

[3]. Leukemic transformation by the MLL-AF6 fusion oncogene requires the H3K79 methyltransferase Dot1l.Blood. 2013 Mar 28;121(13):2533-41.


Solubility Data


Solubility (In Vitro) H2O : ~100 mg/mL (~173.57 mM)
DMSO : ~100 mg/mL (~173.57 mM)
Solubility (In Vivo) Solubility in Formulation 1: 100 mg/mL (173.57 mM) in PBS (add these co-solvents sequentially from left to right, and one by one), clear solution; with sonication.

 (Please use freshly prepared in vivo formulations for optimal results.)
Preparing Stock Solutions 1 mg 5 mg 10 mg
1 mM 1.7357 mL 8.6786 mL 17.3572 mL
5 mM 0.3471 mL 1.7357 mL 3.4714 mL
10 mM 0.1736 mL 0.8679 mL 1.7357 mL
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.